Ultra Market Research | Global Diabetes Care Devices Market
Global Diabetes Care Devices Market
Report ID : 932
Category : Medical-Devices,Global
No Of Pages : 104
Published on: January 2025
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Diabetes Care Devices Market Introduction Global Diabetes Care Devices Market focuses on the medical technologies that are used for diabetes management. These include monitoring and treatment devices, such as blood glucose monitors, insulin delivery systems, and continuous glucose monitors. These are critical in diabetes management and result in better outcomes for patients. The market has grown rapidly as a result of increasing prevalence, lifestyle changes, and technological advances. As of 2023, the market size was greater than $25 billion and will grow at a CAGR of 6.5% during the period from 2024 to 2030. Such innovations as artificial intelligence in glucose monitoring, smartphone-compatible devices, and minimally invasive insulin delivery systems are leading trends driving this market forward.
Segmentation Monitoring Devices • Blood Glucose Monitoring o Self-Monitoring Devices o Continuous Glucose Monitoring (CGM) o Others • Diagnostic Devices o HbA1c Test Kits o Ketone Test Kits
Insulin Delivery Devices • Insulin Pens o Disposable Pens o Reusable Pens • Insulin Pumps o Tethered Pumps o Patch Pumps • Insulin Syringes
Smart Diabetes Care • Wearable Devices o Smart CGMs o Smart Insulin Pens • Mobile Applications o Tracking Apps o Telemedicine Platforms
List of Market Players 1. Medtronic (United States) 2. Abbott Laboratories (United States) 3. Roche Diagnostics (Switzerland) 4. Dexcom, Inc. (United States) 5. Johnson & Johnson (United States) 6. Ascensia Diabetes Care (Switzerland) 7. Tandem Diabetes Care (United States) 8. Insulet Corporation (United States) 9. Novo Nordisk (Denmark) 10. Eli Lilly and Company (United States) 11. Ypsomed (Switzerland) 12. B. Braun Melsungen AG (Germany) 13. Senseonics Holdings, Inc. (United States) 14. ARKRAY, Inc. (Japan) 15. Terumo Corporation (Japan)
Drivers Global Diabetes Care Devices Market is driven by the increasing prevalence of diabetes, which is mainly due to sedentary lifestyles, obesity, and aging populations. Increasing awareness campaigns and initiatives by governments and healthcare organizations have also encouraged the adoption of advanced diabetes care devices. Technological advancements, such as non-invasive glucose monitoring and smartphone integration, have enhanced user convenience and accuracy. The growing demand for remote patient monitoring and personalized treatment has further accelerated market growth. The requirement of better diabetes management solutions in emerging economies, with the improvement in healthcare infrastructure, is promising in markets.
Restraints High cost remains a major obstacle to widespread adoption, especially in emerging markets. Limited exposure to the advanced healthcare technology and a weak insurance coverage further reinforce this factor. Inaccurate readings from devices and periodic calibration often trigger patient dissatisfaction. The process of approvals is also a challenge, which makes allowing new products time-consuming. Other alternatives such as generic drugs and traditional methods of management also create competition for acceptance. Issues with user adherence, particularly in the elderly and illiterate segments, also negatively impact market growth.
Opportunities Emerging economies present a significant growth opportunity for the Global Diabetes Care Devices Market as healthcare investments are increasing and more awareness campaigns are being conducted. Advances in wearable technologies and AI-based analytics present opportunities for effective diabetes management. Tech companies partnering with healthcare providers to develop integrated care solutions are now gaining momentum. The popularity of personalized medicine has opened doors to innovative glucose monitoring and insulin delivery devices. In addition, government efforts at reducing complications that arise from diabetes and promoting superior healthcare technologies foster a fertile soil for growth.
Trends Advancements are driving the Global Diabetes Care Devices Market due to the integration of artificial intelligence for predictive analytics and decision support. Advances in miniaturization, including implantable CGMs, improved user convenience. Smartphone compatible insulin delivery systems and applications for real-time tracking are growing. Telemedicine usage regarding video consultation and observation is now an important trend. Companies are paying much attention to making devices eco-friendly, disposable with disposal and recyclability. Market is being transformed as tech firms are collaborating with healthcare providers to bring integrated systems together.
Approved Products • FreeStyle Libre 3 (Abbott) • Dexcom G7 CGM System • Medtronic MiniMed 780G Insulin Pump • Tandem Diabetes t:slim X2 Insulin Pump • Eversense E3 CGM System
Key Target Audience • Hospitals • Diabetes Care Clinics • Endocrinologists • Healthcare Providers • Pharmaceutical Companies • Research Institutions
Frequently Asked Questions (FAQ's)
Devices used for monitoring and managing diabetes, such as glucose monitors and insulin pumps.
The rising prevalence of diabetes, technology advancements, and demand for personalized care solutions.
Monitoring devices, insulin delivery systems, and smart diabetes care solutions.
North America and Europe lead, with Asia-Pacific emerging rapidly.
AI integration, wearable technology, and telemedicine advancements.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Device Type • Blood Glucose Monitoring Devices o Glucometers o Continuous Glucose Monitoring (CGM) Systems o Lancets o Others • Insulin Delivery Devices o Insulin Pens o Insulin Pumps o Insulin Syringes o Others 3.2.2 By End-User • Hospitals and Clinics • Homecare Settings • Diagnostic Centers • Others 3.2.3 By Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies • Others 3.2.4 By Geography • North America • Europe • Asia-Pacific • Latin America • Middle East & Africa 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
4. Global Diabetes Care Devices Market by Device Type 4.1 Introduction 4.2 Market Size and Growth Rate by Device Type (2024-2030) 4.2.1 Blood Glucose Monitoring Devices • Glucometers • Continuous Glucose Monitoring Systems • Lancets • Others 4.2.2 Insulin Delivery Devices • Insulin Pens • Insulin Pumps • Insulin Syringes • Others
5. Global Diabetes Care Devices Market by End-User 5.1 Introduction 5.2 Market Size and Growth Rate by End-User (2024-2030) 5.2.1 Hospitals and Clinics • Outpatient Clinics • Inpatient Diabetes Units 5.2.2 Homecare Settings • Personal Use Devices • Remote Monitoring Solutions 5.2.3 Diagnostic Centers • Independent Diagnostic Labs • Integrated Diagnostic Labs 5.2.4 Others
6. Global Diabetes Care Devices Market by Distribution Channel 6.1 Introduction 6.2 Market Size and Growth Rate by Distribution Channel (2024-2030) 6.2.1 Hospital Pharmacies • Direct Distribution • Bulk Procurement 6.2.2 Retail Pharmacies • Chain Pharmacies • Standalone Pharmacies 6.2.3 Online Pharmacies • E-commerce Platforms • Company-Owned Websites 6.2.4 Others
7. Global Diabetes Care Devices Market by Geography 7.1 Introduction 7.2 Market Size and Growth Rate by Region (2024-2030) 7.2.1 North America • United States • Canada 7.2.2 Europe • Germany • United Kingdom • France • Rest of Europe 7.2.3 Asia-Pacific • China • Japan • India • Southeast Asia • Rest of Asia-Pacific 7.2.4 Latin America • Brazil • Mexico • Rest of Latin America 7.2.5 Middle East & Africa • GCC • North Africa • South Africa • Rest of Middle East & Africa
8. Competitive Landscape 8.1 Company Profiles 8.1.1 Medtronic (United States) 8.1.2 Abbott Laboratories (United States) 8.1.3 Dexcom, Inc. (United States) 8.1.4 F. Hoffmann-La Roche AG (Switzerland) 8.1.5 Novo Nordisk A/S (Denmark) 8.1.6 Sanofi (France) 8.1.7 Eli Lilly and Company (United States) 8.1.8 Ascensia Diabetes Care (Switzerland) 8.1.9 Becton, Dickinson and Company (United States) 8.1.10 Tandem Diabetes Care (United States) 8.1.11 Ypsomed AG (Switzerland) 8.1.12 Insulet Corporation (United States) 8.1.13 Terumo Corporation (Japan) 8.1.14 Arkray, Inc. (Japan) 8.1.15 AgaMatrix, Inc. (United States)
9. List of Tables and Figures • Table 1: Global Diabetes Care Devices Market by Device Type, 2024-2030 • Table 2: Regional Market Size Analysis, 2024-2030 • Figure 1: Market Dynamics - Drivers, Restraints, and Opportunities • Figure 2: Market Share Analysis by Device Type (2024) • Figure 3: Competitive Landscape - Company Market Share (2024)
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Diabetes Care Devices Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Diabetes Care Devices Market for the past year and forecasts for the next six years. Global Diabetes Care Devices Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Diabetes Care Devices Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global Diabetes Care Devices Market from different application industries in different regions.
Segmentation Monitoring Devices • Blood Glucose Monitoring o Self-Monitoring Devices o Continuous Glucose Monitoring (CGM) o Others • Diagnostic Devices o HbA1c Test Kits o Ketone Test Kits
Insulin Delivery Devices • Insulin Pens o Disposable Pens o Reusable Pens • Insulin Pumps o Tethered Pumps o Patch Pumps • Insulin Syringes
Smart Diabetes Care • Wearable Devices o Smart CGMs o Smart Insulin Pens • Mobile Applications o Tracking Apps o Telemedicine Platforms
